|Articles|November 8, 1995

Positron wins order for PET camera

Positron has received an order for a Posicam HZL PET camera, thefourth such order the Houston company has won since April, whenthe Health Care Financing Administration granted Medicare reimbursementfor rubidium-82 studies (SCAN 4/12/95). The order was

Positron has received an order for a Posicam HZL PET camera, thefourth such order the Houston company has won since April, whenthe Health Care Financing Administration granted Medicare reimbursementfor rubidium-82 studies (SCAN 4/12/95). The order was placed bythe Metropolitan Cardiac Institute in Chevy Chase, MD, accordingto the company.

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Subscribe Now!

Latest CME

Video

26th Annual International Lung Cancer Congress

Roy S. Herbst, MD, PhD; Sandip Patel, MD, FASCO; Heather A. Wakelee, MD, FASCO

Positron wins order for PET camera

Newsletter

Related Content

Diagnostic Imaging’s Weekly Scan: October 26 — November 1

Emerging Trends with Radiology Practice Closures Point to Increased Subspecialization

Sirona Medical Receives FDA Clearance for Advanced Imaging Suite

Maintaining Quality Standards for Breast Imaging Amid Rising Imaging Volumes: An Interview with Deepa Sheth, MD

Can a Generative AI Platform Enhance Workflow Triage and Efficiency in Radiology?

Latest CME

26th Annual International Lung Cancer Congress

Community Oncology Connections™: Beyond the Basics—Revolutionizing Advanced Prostate Cancer Management With PSMA-Targeted Therapies | South Carolina

43rd Annual CFS®: Innovative Cancer Therapy for Tomorrow™

20th Annual New York Lung Cancers Symposium®

Community Oncology Connections™: Beyond the Basics—Revolutionizing Advanced Prostate Cancer Management With PSMA-Targeted Therapies | West Virginia

Community Oncology Connections™: Beyond the Basics—Revolutionizing Advanced Prostate Cancer Management With PSMA-Targeted Therapies | Tennessee

Inaugural Brain & Spine Metastases Conference: Evolving Practice and Emerging Therapies

2nd Annual Hawaii Cancer Conference

23rd Annual Winter Lung Cancer Conference®

43rd Annual Miami Breast Cancer Conference®

19th Annual New York GU Cancers Congress™

Mastering Advances in Managing Unresectable and Metastatic NSCLC—Immunotherapy, Targeted Therapies, and Emerging Strategies

Cases & Conversations™: Expert Perspectives on Leveraging Recent Advances to Transform SCLC Treatment

Community Practice Connections™: Empowering Interventional Radiologists in the Emerging Era of Oncolytic Immunotherapies for Melanoma

17th Annual International Symposium on Ovarian Cancer and Other Gynecologic Malignancies™

(CME Credit) Advancing Outcomes in Limited-Stage Small Cell Lung Cancer: From Evidence to Practice

PER Tumor Board®: Applying Recent Advances to Transform the Treatment Paradigm in SCLC—Expert Perspectives on New Approvals and Emerging Strategies

Ready for Radioligand Therapy? Patient Selection and Sequencing Simplified

Radioligand Therapy 101: The Science Behind the Strategy

Working Together: Overcoming Barriers to Optimize Outcomes in Patients Treated With Radioligand Therapy Through Multidisciplinary Care

BURST CME™ Resource Center: Integrating Novel PSMA-Directed Radioligand Approaches for Diagnosis and Management of Prostate Cancer

Community Practice Connections™: Beyond the Basics— Revolutionizing Advanced Prostate Cancer Management With PSMA-Targeted Therapies

2026 International Symposium of Gastrointestinal Oncology (ISGIO)

26th Annual International Lung Cancer Congress

Enhancing Prostate Cancer Outcomes – The Role of PSMA and Targeted Treatment Strategies

Trending on Diagnostic Imaging

Fujifilm Sonosite Unveils Next-Generation Point-of-Care Ultrasound Device

Can Contrast-Enhanced Mammography Offer a Viable Option for Pre-Op Assessment of Pathologic Nipple Involvement?

A Closer Look at New Guidelines for Molecular Imaging of Renal Masses: An Interview with Steven Rowe, MD, Part 1

Can Ultrasound-Derived Fat Fraction Provide a Viable Alternative for Quantifying Hepatic Steatosis?